W Conrad Liles

Title: W. Conrad Liles: Innovator in Immunotherapy Biomarkers

Introduction

W. Conrad Liles, based in Seattle, WA, is a noteworthy inventor making significant strides in the field of immunotherapy. With a total of two patents to his name, his work focuses on identifying biomarkers that can guide interventions and treatments for critical medical conditions, particularly in the context of immunotherapy.

Latest Patents

Liles' latest patents encompass groundbreaking advancements in the identification and use of biomarkers related to cytokine release syndrome (CRS) and neurotoxicity. One of his key disclosures outlines methods for identifying subjects at risk of developing these adverse events after adoptive immunotherapy. This innovation allows healthcare providers to guide preemptive interventions and modified therapies effectively. Liles outlines exemplary biomarkers such as temperature, cytokine levels, and endothelial activation biomarkers, which include angiopoietin 2 and von Willebrand factor.

Additionally, his patent concerning biomarkers for early determination of critical or life-threatening responses focuses on utilizing novel biomarker combinations to predict patient outcomes. These biomarkers serve as essential tools for determining treatment options and monitoring the effectiveness of interventions for individuals facing critical illnesses, showcasing Liles' commitment to improving patient care.

Career Highlights

W. Conrad Liles’ career has been marked by his roles at prominent institutions such as Fred Hutchinson Cancer Center and the University of Washington. His association with these respected organizations highlights his dedication to advancing medical science and patient safety through innovative research and development.

Collaborations

Throughout his career, Liles has collaborated with esteemed professionals in his field, including Cameron J. Turtle and David G. Maloney. These collaborations have undoubtedly enriched his work, allowing for the exchange of ideas and promoting advancements in immunotherapy and biomarker research.

Conclusion

W. Conrad Liles stands out as a key inventor in the realm of immunotherapy, with his patents showcasing his innovative approaches to detecting and managing critical medical responses. His contributions promise to enhance the safety and effectiveness of treatment interventions for patients at risk of severe adverse events, marking him as an influential figure in the medical research community.